Date Published
Country
Source
Videos
close
-
The Future of Pharmaceutical Pricing
Listen in to hear more about the future of pharmaceutical pricing, focusing on the three key issues of affordability, evidence and value attribution. -
Physician-Administered Therapies: Access Strategies & Insights
Listen in to hear tips for pharma manufacturers as they develop their market access strategies and prepare to launch physician-administered therapies.Comments
No comments yet. Create an account and log in to post a comment.
-
Are Drug Prices Too High? Should QALYs Be Used to Measure a Drug's Value? And Should a Government Entity Be Making Price and Value Determinations? A Conversation with Dan Ollendorf.
Dan Ollendorf, Ph.D., M.P.H.,of the Center for the Evaluation of Value and Risk in Health at Tufts University Medical Center, is co-author of a new book, The Right Price, A Value-Based Prescription for Drug Costs.Comments
No comments yet. Create an account and log in to post a comment.
-
Steven D. Pearson Shares if PCSK9 Pricing Put ICER on Map
Steven D. Pearson, M.D., M.Sc., founder and president of ICER addresses if pricing of PCSK9 inhibitors put ICER on the map.Comments
No comments yet. Create an account and log in to post a comment.
-
Stephen Pearson of ICER Talks Access and Price of Cholesterol Agents
Can price affect access?
Comments
No comments yet. Create an account and log in to post a comment.
-
Are Ultra-High Drug Prices Sustainable?
Discussion on high-priced drugs and whether the prices are sustainable in the long run.Comments
No comments yet. Create an account and log in to post a comment.
Comments